Generate Investment Management Ltd Has $8.70 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Generate Investment Management Ltd trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 72.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 25,164 shares of the company's stock after selling 66,580 shares during the quarter. Generate Investment Management Ltd's holdings in HCA Healthcare were worth $8,695,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also made changes to their positions in HCA. Atwood & Palmer Inc. acquired a new position in HCA Healthcare during the first quarter valued at approximately $28,000. Whipplewood Advisors LLC acquired a new position in HCA Healthcare during the fourth quarter valued at approximately $31,000. Tidemark LLC acquired a new position in HCA Healthcare during the fourth quarter valued at approximately $36,000. ORG Partners LLC grew its holdings in HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after purchasing an additional 86 shares during the last quarter. Finally, Legacy Investment Solutions LLC grew its holdings in HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after purchasing an additional 95 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

Shares of NYSE:HCA traded up $1.34 on Friday, hitting $379.00. The stock had a trading volume of 1,554,834 shares, compared to its average volume of 1,478,315. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19. The firm's 50 day moving average price is $366.55 and its 200-day moving average price is $336.76. The company has a market capitalization of $91.18 billion, a price-to-earnings ratio of 16.85, a price-to-earnings-growth ratio of 1.30 and a beta of 1.49.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The company had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. During the same quarter in the previous year, the company earned $5.36 EPS. The firm's revenue for the quarter was up 5.7% compared to the same quarter last year. On average, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.76%. HCA Healthcare's dividend payout ratio (DPR) is 12.81%.

Insider Buying and Selling

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer now directly owns 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.30% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on HCA shares. Morgan Stanley set a $410.00 target price on shares of HCA Healthcare and gave the stock an "equal weight" rating in a research report on Monday, June 9th. Wall Street Zen lowered shares of HCA Healthcare from a "buy" rating to a "hold" rating in a research report on Friday. Guggenheim started coverage on shares of HCA Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating on the stock. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and boosted their target price for the stock from $320.00 to $385.00 in a research report on Thursday, May 29th. Finally, Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Eight investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $394.33.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.